Cargando…
SARS-CoV-2 rapid diagnostic testing: Canadian consensus guidance for pharmacists
Autores principales: | Sihota, Aaron, Barrett, Brett, Bonell, Cameron, Chehade, Ahmad, Dhaliwal, Jerry, Kani, Michael, Kellar, Jamie, Kwong, Conny, Ravinatarajan, Pavithra, Schwartz, Kevin L., Smith, Stacey, Thiffault, Jean, Woit, Cassandra, Vaisman, Alon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116221/ https://www.ncbi.nlm.nih.gov/pubmed/37197090 http://dx.doi.org/10.1177/17151635231164631 |
Ejemplares similares
-
Canadian national consensus guidelines for naloxone prescribing by pharmacists
por: Tsuyuki, Ross T., et al.
Publicado: (2020) -
Monitoring the transition of patients on biologics in rheumatoid arthritis: Consensus guidance for pharmacists
por: Choquette, Denis, et al.
Publicado: (2021) -
Resources and interventions to support psychological health and wellbeing in the pharmacy workforce: Analysis and use of a health worker ‘burnout’ toolkit()
por: Mulherin, Katrina, et al.
Publicado: (2023) -
Knowledge, attitudes and beliefs about chronic noncancer pain in primary care: A Canadian survey of physicians and pharmacists
por: Lalonde, Lyne, et al.
Publicado: (2014) -
Canadian Association of Radiologists Guidance on Contrast-Associated Acute Kidney Injury
por: Macdonald, D. Blair, et al.
Publicado: (2022)